StockNews.AI
WBA
StockNews.AI
179 days

March 31, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against WBA

1. Lawyers file a class action lawsuit against Walgreens. Investors are alerted. 2. Lawsuit spans April 2020 to January 2025 misconduct. Claims impact regulatory compliance. 3. Allegations include false statements and regulatory violations. Reputational harm is possible.

4m saved
Insight
Article

FAQ

Why Bearish?

The lawsuit alleges securities fraud and regulatory violations that could depress investor sentiment. Similar cases in the past, like those involving significant regulatory concerns, led to a short-term decline in stock prices.

How important is it?

The class action lawsuit may trigger immediate volatility and heightened legal scrutiny. Although fundamentals may remain stable, legal exposure can lead to short-term pricing pressure.

Why Short Term?

Market reaction is expected soon due to legal and reputational risk. Historical litigation events have caused short-term volatility without altering long-term fundamentals.

Related Companies

CVS
NEW YORK, Feb. 21, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Walgreens Boots Alliance, Inc. ("Walgreens" or the "Company") (NASDAQ: WBA) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Walgreens investors who were adversely affected by alleged securities fraud between April 2, 2020 and January 16, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com/pslra-1/walgreens-boots-alliance-inc-lawsuit-submission-form-2?prid=130866&wire=4 WBA investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: The filed complaint alleges that defendants made false statements and/or concealed that: (i) contrary to the Company's purported commitment to improved regulatory compliance, Walgreens continued to engage in widespread violations of federal law governing the dispensation of prescription medication and reimbursement for the same; (ii) the foregoing conduct, when revealed, would subject Walgreens to a heightened risk of further regulatory scrutiny, civil liability, and reputational harm; (iii) Walgreens' revenues from the sale of prescription medications were unsustainable to the extent that they derived from unlawful conduct; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times. WHAT'S NEXT? If you suffered a loss in Walgreens during the relevant time frame, you have until March 31, 2025 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the past 20 years, the team at Levi & Korsinsky has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. Our firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. CONTACT:Levi & Korsinsky, LLP Joseph E. Levi, Esq.Ed Korsinsky, Esq.33 Whitehall Street, 17th FloorNew York, NY 10004[email protected]Tel: (212) 363-7500Fax: (212) 363-7171www.zlk.com SOURCE Levi & Korsinsky, LLP

Related News